Dr. Essam Hamza reports

ROCKET DOCTOR APPOINTS TWO SENIOR LEADERS, BRINGING EXTENSIVE BACKGROUNDS ACROSS DIGITAL HEALTH, AI-DRIVEN CLINICAL PRODUCT DEVELOPMENT and SCALABLE ENTERPRISE PLATFORMS

Rocket Doctor AI Inc.'s wholly owned subsidiary Rocket Doctor Inc. has appointed two additional senior leaders to its team as part of a strategic initiative to advance its digital health platform and marketplace, strengthen product and engineering capabilities and support continued growth across North America. Dr. Anikia Nelson joins as director of product and Bilal Malik as director of engineering, where they will be responsible for overseeing and enhancing product direction, platform innovation, scalability and platform interoperability -- liaising between the company's clinical and technology teams.

Dr. Nelson joins Rocket Doctor with deep expertise at the intersection of clinical care, product strategy and artificial-intelligence-driven health care innovation. A physician by training, she brings over a decade of experience translating complex clinical workflows into scalable digital products.

Prior to Rocket Doctor, Dr. Nelson was a physician strategy manager at Doximity, where she led clinical workflow design and generative AI use-case development for products including Doximity GPT and Scribe, driving physician adoption across care settings. She also previously served as senior director, clinical product management, at Clarify Health Solutions, leading product development and commercialization for payer-facing analytics platforms supporting value-based care and national market adoption and earlier contributed to product strategy at Milliman. In her role as director of product, Dr. Nelson will lead Rocket Doctor's product vision and road map, focusing on delivering solutions that physicians can trust and adopt.

Mr. Malik brings more than a decade of experience leading engineering teams and building scalable, high-performance systems across health care and enterprise environments, with expertise in AI-enabled cloud-native platforms.

Prior to Rocket Doctor, Mr. Malik was head of AI strategy and practice at Pricedex Software, where he led the development of agentic AI frameworks to automate complex software development workflows and improve engineering velocity. He previously served as director of software development at Pricedex, and director of professional services and program management at Cinnova Technologies, leading large-scale digital transformation initiatives across industries.

Across his career, Mr. Malik has built distributed systems supporting billions in transaction volume, delivered HIPAA-compliant platforms and led organizations through SOC 2 and ISO 27001 readiness. As director of engineering, he will oversee Rocket Doctor's engineering organization, focusing on scalability, AI integration and secure, high-performance infrastructure.

"We're thrilled to welcome Dr. Nelson and Bilal to the Rocket Doctor team," said Dr. William Cherniak, co-founder and chief executive officer of Rocket Doctor Inc. "Dr. Nelson brings a powerful combination of clinical expertise and product leadership, while Bilal's experience scaling complex platforms will be critical as we continue to grow and innovate. Together, they strengthen our ability to make high-quality healthcare more accessible through technology."

The company further announces that it has granted an aggregate 143,388 restricted share units (RSUs) and 5,738 stock options to consultants and employees of the company and its subsidiary, Rocket Doctor Inc.

The options are each exercisable for one common share of the company at an exercise price of 70 cents per share for a period of three years from the grant date and subject to vesting provisions. The RSUs are valid for a term of three years and are subject to vesting provisions. All options and RSUs are subject to the terms of the company's equity plans and applicable securities law hold periods.

About Rocket Doctor AI Inc.

Rocket Doctor AI delivers physician-built, AI-powered solutions designed to make high-quality health care accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

We seek Safe Harbor.